Bylvay may provide the itch relief you want,
without surgery.

Yellow circle with graphic depicting person with light shining around them.

What to Expect

Find out all about Bylvay and what to expect with treatment

Yellow circle with graphic depicting person surrounded by connecting circles illustration.

Albireo Assist: Helping Navigate the Way

Patients and families have access to a dedicated patient support program for Bylvay.

Yellow circle with graphic depicting prescription bottle.

How to Take Bylvay

Information to help you take Bylvay as your doctor prescribes.

Yellow circle with graphic depicting a liver.

Understanding PFIC

Progressive familial intrahepatic cholestasis (PFIC) is a spectrum of rare, inherited, liver diseases.

IMPORTANT SAFETY INFORMATION AND INDICATION

Important Safety Information

Speak with your healthcare provider if you experience: abdominal pain, vomiting, diarrhea, and dehydration as these have been reported with the use of Bylvay. Contact your healthcare provider if you experience new or worsening diarrhea, or dehydration.

Increases in the amounts of some liver enzymes (for example, AST, ALT, TB) have been seen with use of Bylvay. Your healthcare provider will run liver tests before and during treatment with Bylvay. You should report to your healthcare provider any symptoms of liver problems (for example, nausea, vomiting, skin or the whites of eyes turn yellow, dark or brown urine, pain on the right side of the abdomen, loss of appetite).

Bylvay may reduce the body’s ability to absorb fat-soluble vitamins (FSV), which include vitamins A, D, E and K. Your healthcare provider will measure blood levels of these vitamins before and during treatment with Bylvay.

Do not mix Bylvay with liquids.

Do not swallow the 200 mcg or 600 mcg capsule(s) containing Oral Pellets whole. These are intended to be opened and the contents mixed into soft food. Take Bylvay in the morning with a meal.

For patients taking bile acid binding resins, take Bylvay at least 4 hours before or 4 hours after taking a bile acid binding resin.

INDICATIONS AND USAGE

Bylvay is indicated for the treatment of pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC).

Limitation of Use

Bylvay may not be effective in PFIC type 2 patients with ABCB11 variants resulting in non-functional or complete absence of bile salt export pump protein (BSEP-3).

Please see full Prescribing Information.

IMPORTANT SAFETY INFORMATION AND INDICATION

IMPORTANT SAFETY INFORMATION

Speak with your healthcare provider if you experience: abdominal pain, vomiting, diarrhea, and dehydration as these have been reported with the use of Bylvay. Patients should contact their healthcare provider if they experience new onset or worsening of diarrhea.

Elevations in liver tests (for example, AST, ALT, TB) have been observed with use of Bylvay. The patient’s health care provider will obtain liver tests before starting Bylvay and periodically during treatment with Bylvay. Patients should report to their healthcare provider any symptoms of liver problems (for example, nausea, vomiting, skin or the whites of eyes turn yellow, dark or brown urine, pain on the right side of the abdomen, loss of appetite).

Bylvay may impair absorption of fat-soluble vitamins (FSV), which include vitamins A, D, E and K (vitamin K is assessed by measuring INR). The patient’s health care provider will obtain serum levels of vitamins A, D, E, and INR (for vitamin K) at baseline and periodically during treatment to assess for worsening of FSV deficiency.

Do not mix Bylvay with liquids.

Do not swallow the 200 mcg or 600 mcg capsule(s) containing Oral Pellets whole. These are intended to be opened and the contents mixed into soft food. Take Bylvay in the morning with a meal.

For patients taking bile acid binding resins, take Bylvay at least 4 hours before or 4 hours after taking a bile acid binding resin.

INDICATIONS AND USAGE

Bylvay is indicated for the treatment of pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC).

Limitation of Use

Bylvay may not be effective in PFIC type 2 patients with ABCB11 variants resulting in non-functional or complete absence of bile salt export pump protein (BSEP-3).

Please see full Prescribing Information.